2.2912
전일 마감가:
$2.355
열려 있는:
$2.33
하루 거래량:
11,514
Relative Volume:
0.34
시가총액:
$7.35M
수익:
$556.00K
순이익/손실:
$-5.28M
주가수익비율:
-1.0707
EPS:
-2.14
순현금흐름:
$-6.23M
1주 성능:
-11.66%
1개월 성능:
-27.03%
6개월 성능:
-45.58%
1년 성능:
-24.13%
Cyclerion Therapeutics Inc Stock (CYCN) Company Profile
명칭
Cyclerion Therapeutics Inc
전화
617-621-7722
주소
301 BINNEY STREET, CAMBRIDGE, MA
CYCN을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
CYCN
Cyclerion Therapeutics Inc
|
2.2912 | 8.51M | 556.00K | -5.28M | -6.23M | -2.14 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
![]()
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2021-10-20 | 개시 | Truist | Buy |
2021-09-24 | 개시 | Cantor Fitzgerald | Overweight |
2019-06-03 | 개시 | Credit Suisse | Neutral |
Cyclerion Therapeutics Inc 주식(CYCN)의 최신 뉴스
How to build a dashboard for Cyclerion Therapeutics Inc. stockFree Weekly Growth Stock Entry Point Alerts - Newser
Will Cyclerion Therapeutics Inc. rebound enough to break evenRisk Managed Watchlist with Breakout Picks - Newser
Heatmap analysis for Cyclerion Therapeutics Inc. and competitorsFree Daily Chart Pattern Stock Forecast - Newser
Cyclerion Therapeutics Inc. stock chart pattern explainedChart Driven Opportunity Scanner with Alerts - Newser
Institutional scanner results for Cyclerion Therapeutics Inc.Risk-Managed Swing Setup and Signal Analysis - Newser
Does Cyclerion Therapeutics Inc. show high probability of reboundAI-Based Signal Detection for Active Traders - Newser
Can machine learning forecast Cyclerion Therapeutics Inc. recoveryWeekly Chart-Based Forecast for Traders - Newser
Using data tools to time your Cyclerion Therapeutics Inc. exitNear-Term Market Opportunity Forecast Sheet - Newser
How Cyclerion Therapeutics Inc. stock performs during market volatilityWatchlist Generator With Real-Time Entry - Newser
Will Cyclerion Therapeutics Inc. outperform the marketStock Portfolio Risk and Return Analysis - Newser
Is Cyclerion Therapeutics Inc. showing signs of accumulationStock Entry Point Planner with Volume Spike - Newser
Quantitative breakdown of Cyclerion Therapeutics Inc. recent moveFree Fundamental Growth Stock Analysis - Newser
Cyclerion Therapeutics, Inc. SEC 10-Q Report - TradingView
What are analysts’ price targets for Cyclerion Therapeutics Inc. in the next 12 monthsInvest confidently with professional market insights - Jammu Links News
What catalysts could drive Cyclerion Therapeutics Inc. stock higher in 2025Build wealth steadily with proven stock picks - Jammu Links News
What are Cyclerion Therapeutics Inc. company’s key revenue driversGet timely alerts on top market movers - Jammu Links News
Is Cyclerion Therapeutics Inc. stock overvalued or undervaluedInvest confidently with proven investment plans - Jammu Links News
What are the technical indicators suggesting about Cyclerion Therapeutics Inc.Get exclusive market analysis for investors - Jammu Links News
How many analysts rate Cyclerion Therapeutics Inc. as a “Buy”High-octane gains - Jammu Links News
How does Cyclerion Therapeutics Inc. generate profit in a changing economyUnlock powerful stock screening tools - Jammu Links News
Why is Cyclerion Therapeutics Inc. stock attracting strong analyst attentionGet ahead with breakthrough trading ideas - Jammu Links News
Cyclerion Therapeutics Inc. Stock Analysis and ForecastExceptional ROI - Jammu Links News
What analysts say about Cyclerion Therapeutics Inc. stockAchieve rapid growth with smart investments - Jammu Links News
What makes Cyclerion Therapeutics Inc. stock price move sharplyFree Stock Target Finder For Fast Growth - Jammu Links News
Visual trend scoring systems applied to Cyclerion Therapeutics Inc.Free Breakout Momentum Picks With Protection - Newser
Why Cyclerion Therapeutics Inc. stock attracts strong analyst attentionSwing Trade Planning with Consistent Setup - Newser
Cyclerion Therapeutics Inc (CYCN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):